Literature DB >> 17095132

Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.

Hirofumi Suzuki1, Ronald T Riley, Raghubir P Sharma.   

Abstract

Fumonisin B(1), a mycotoxin, is an inhibitor of ceramide synthase causing marked dysregulation of sphingolipid metabolism in cells. This mycotoxin causes accumulation of free sphingoid bases (sphingosine and dihydrosphingosine or sphinganine) and their metabolites, important messengers involved in signal transduction leading to either cell survival or death. Free sphingoid bases are known apoptotic molecules whereas sphingosine 1-phosphate is protective. We previously reported that fumonisin B(1) caused sphingosine kinase (SPHK) induction along with the increase of serine palmitoyltransferase (SPT). Fumonisin B(1) also increased inducible nitric oxide synthase (iNOS) expression. In the current study we employed a mouse strain with the targeted deletion of iNOS gene (Nos-KO) to evaluate the role of nitric oxide (NO) on fumonisin B(1)-induced hepatotoxicity. The Nos-KO mice exhibited increased hepatotoxicity after subacute fumonisin B(1) exposure compared to their wild type counterparts, the liver regeneration was lower in Nos-KO compared to that in the WT mice. Increased hepatotoxicity in Nos-KO was not related to the extent of free sphingoid base accumulation after fumonisin B(1) treatment; however, it was accompanied by a lack of fumonisin B(1)-induced SPHK induction. The fumonisin B(1)-induced SPT was unaffected by lack of iNOS gene. Deletion of iNOS gene did not prevent fumonisin B(1)-dependent induction of inflammatory cytokines, namely tumor necrosis factor alpha, interferon gamma and interleukin-12. The lack of fumonisin B(1)-induced SPHK induction in Nos-KO was supported by a similar effect on phosphorylated metabolites of sphingoid bases; the equilibrium between sphingoid bases and their phosphates is maintained by SPHK. We therefore conclude that iNOS induction produced by fumonisin B(1) modulates SPHK activity; the lack of iNOS prevents generation of sphingosine 1-phosphate and deprives cells from its protective effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095132      PMCID: PMC1850950          DOI: 10.1016/j.tox.2006.09.010

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  53 in total

1.  Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine.

Authors:  Raghubir P Sharma; Quanren He; Ronald T Riley
Journal:  Toxicology       Date:  2005-09-12       Impact factor: 4.221

2.  Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride.

Authors:  Quanren He; Jiyoung Kim; Raghubir P Sharma
Journal:  Toxicology       Date:  2005-02-01       Impact factor: 4.221

3.  Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.

Authors:  Quanren He; Hirofumi Suzuki; Neelesh Sharma; Raghubir P Sharma
Journal:  Toxicol Sci       Date:  2006-09-07       Impact factor: 4.849

4.  Carbon monoxide and nitric oxide protect against tumor necrosis factor-alpha-induced apoptosis in osteoblasts: HO-1 is necessary to mediate the protection.

Authors:  H J Chae; H Y Chin; G Y Lee; H R Park; S K Yang; H T Chung; H O Pae; H M Kim; S W Chae; H R Kim
Journal:  Clin Chim Acta       Date:  2005-10-19       Impact factor: 3.786

5.  Amelioration of fumonisin B1 hepatotoxicity in mice by depletion of T cells with anti-Thy-1.2.

Authors:  Neelesh Sharma; Quanren He; Raghubir P Sharma
Journal:  Toxicology       Date:  2006-04-18       Impact factor: 4.221

6.  Nitric oxide regulates synthesis of gene products involved in keratinocyte differentiation and ceramide metabolism.

Authors:  Hichem Gallala; Oliver Macheleidt; Thomas Doering; Volker Schreiner; Konrad Sandhoff
Journal:  Eur J Cell Biol       Date:  2004-12       Impact factor: 4.492

7.  Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells.

Authors:  Neelesh Sharma; Quanren He; Raghubir P Sharma
Journal:  Chem Biol Interact       Date:  2004-12-30       Impact factor: 5.192

8.  Signal transduction pathways of nitric oxide release in primary microglial culture challenged with gram-positive bacterial constituent, lipoteichoic acid.

Authors:  H F Chien; K Y Yeh; Y F Jiang-Shieh; I H Wei; C Y Chang; M L Chang; C H Wu
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

9.  Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2-deficient mice.

Authors:  V E Laubach; P L Foley; K S Shockey; C G Tribble; I L Kron
Journal:  Am J Physiol       Date:  1998-12

10.  Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.

Authors:  M Tsunoda; R P Sharma; R T Riley
Journal:  J Biochem Mol Toxicol       Date:  1998       Impact factor: 3.642

View more
  5 in total

1.  Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formation.

Authors:  Stephanie Schwalm; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages.

Authors:  Samar M Hammad; Heather G Crellin; Bill X Wu; Jessica Melton; Viviana Anelli; Lina M Obeid
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-11-24       Impact factor: 3.072

3.  FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.

Authors:  Evgeny V Berdyshev; Irina Gorshkova; Anastasia Skobeleva; Robert Bittman; Xuequan Lu; Steven M Dudek; Tamara Mirzapoiazova; Joe G N Garcia; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2009-01-01       Impact factor: 5.157

4.  Silencing of enzymes involved in ceramide biosynthesis causes distinct global alterations of lipid homeostasis and gene expression.

Authors:  Wanida Ruangsiriluk; Shaun E Grosskurth; Daniel Ziemek; Max Kuhn; Shelley G des Etages; Omar L Francone
Journal:  J Lipid Res       Date:  2012-05-23       Impact factor: 5.922

5.  DMS triggers apoptosis associated with the inhibition of SPHK1/NF-κB activation and increase in intracellular Ca2+ concentration in human cancer cells.

Authors:  Kan Chen; Qiuwei Pan; Ying Gao; Xinyan Yang; Shibing Wang; Maikel P Peppelenbosch; Xiangdong Kong
Journal:  Int J Mol Med       Date:  2013-10-30       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.